PharmiWeb2h
High Content Screening Market Set for Robust Growth USD 3 Billion with a 5.8% of CAGR, Expanding Drug Discovery Applications
High Content Screening MarketThe global high content screening (HCS) market is poised for steady expansion, with its valuation expected to reach USD 1.6 billion in 2022 and a projected compound annual ...
PharmiWeb2h
China’s First Aid Market Poised for Steady Growth Amid Rising Demand for Wound Care Solutions
China’s First Aid MarketThe China first aid market, valued at USD 266.5 million in 2014, is projected to grow at a compound annual growth rate (CAGR) of 6.3% over the forecast period. Basic first aid ...
PharmiWeb12h
Cold Chain Technologies and Tower Cold Chain Celebrate Landmark Sustainability Achievements
Cold Chain Technologies (CCT) and Tower Cold Chain, a subsidiary of CCT, have reached important milestones in their ongoing ...
PharmiWeb12h
Since 2021, Moderna has launched 23 clinical trials across 110 UK sites
Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...
PharmiWeb20h
Double-Digit Tariffs Disrupt U.S. Healthcare Costs and Supply Chain Stability, Industry Leaders Warn in Black Book Poll
New Black Book Research survey reveals industry-wide concerns as tariffs on imports from Mexico, Canada, and China threaten ...
PharmiWeb5h
First Participants Vaccinated with IAVI’s Ebola Sudan Vaccine Candidate in Uganda Amid Ebola Outbreak
The vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants ...
PharmiWeb7h
The Arthritis Foundation Celebrates 25 Years of the California Coast Classic Bike Tour and Launches the Inaugural Carolina Hills Classic
ATLANTA, GA / ACCESS Newswire / February 3, 2025 / For 25 years, the award-winning Arthritis Foundation California Coast Classic Bike Tour has been a cornerstone event for cyclists and arthritis ...
PharmiWeb7h
Exxel Pharma's Innovative Small Molecule, EX937, Rapidly Advancing Toward First-In-Human Study for the Treatment of Refractory Chronic Cough
Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global marketFirst-in-human Phase 1/1b single/multiple dose study in ...
PharmiWeb7h
CHMP recommends subcutaneous RYBREVANT® (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...
PharmiWeb7h
DEXIS Reflects on a Year of Innovation and Unveils Exciting Plans for 2025
QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with ...
PharmiWeb7h
New sustainable plant-based membrane works without fossil-fuel materials and toxic solvents
They are used in cleaning our drinking water, treating sewage, processing foods and keeping pharmaceuticals safe – membranes are a crucial part of everyday life. Now, chemical engineers at the ...
PharmiWeb12h
Dedalus Surges Ahead in Europe & Latin America: Black Book Research's Top-Ranked Digital Health Leader
Ranked #1 in EHR & Digital Health Solutions by Black Book Research surveys of nearly 28,000 global EHR users-Leading Innovation Across All Spanish-Speaking Latin American Countries, Germany, Austria, ...